Skip to content

Temporomandibular Joint Eminence Augmentation Using Titanium Ring Inlay: A New Surgical Technique

Temporomandibular Joint Eminence Augmentation Using Titanium Ring Inlay: A New Surgical Technique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06936072
Enrollment
112
Registered
2025-04-20
Start date
2024-04-28
Completion date
2025-04-03
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Augmentation, TMJ, TMJ - Oral &Amp;Maxillofacial Surgery

Keywords

TMJ, TMJ augmentation, Augmentation, Oral and Maxillofacial surgery

Brief summary

To evaluate the efficacy of titanium ring inlay in ESS technique in Temporomandibular joint eminence augmentation

Detailed description

Background:Temporomandibular joint (TMJ) disorders affect approximately 5-12% of the population, with eminence augmentation being a challenging surgical intervention. Current techniques using autogenous grafts or alloplastic materials present limitations including donor site morbidity, resorption, and implant failure. This study evaluates a novel titanium ring inlay technique for TMJ eminence augmentation, which may offer improved stability, osseointegration, and functional outcomes. Patients and Methods: A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee, Faculty of Dentistry, Sinai University OMS 01-04-024; . Titanium ring inlay procedure was performed to Temporomandibular joint eminence augmentation. Preoperative and postoperative assessments included pain levels (VAS pain), maximum mouth opening (MMO), Clicking during mouth opening, Headach presence, tinnitus and subjective patient feedback.

Interventions

PROCEDURETitanium Ring Inlay Eminence Augmentation

* Preauricular approach with subperiosteal dissection * Dual osteotomy (transverse mid-eminence + vertical parallel to skull base) * Titanium ring inlay placement with anatomical contouring * Intraoperative functional assessment

Sponsors

Menoufia University
CollaboratorOTHER
Sinai University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee, Faculty of Dentistry, Sinai University OMS 01-04-024.

Eligibility

Sex/Gender
ALL
Age
25 Years to 41 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed TMJ dysfunction requiring eminence augmentation * Failed conservative management (≥3 months) * Adequate bone stock for inlay placement * Willingness to comply with follow-up protocol

Exclusion criteria

* Systemic conditions contraindicating surgery * Active TMJ infection * Previous TMJ surgery * Pregnancy * Neuromuscular disorders-

Design outcomes

Primary

MeasureTime frameDescription
Functional improvementBaseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).Measuring the Maximal interincisal opening (MIO; mm)

Secondary

MeasureTime frameDescription
Pain ScoreBaseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).Measuring the Visual Analogue Scale (VAS), pain score (1-10)
HeadacheBaseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).Measuring the Headache Assessment Presence Yes/No
TinnitusBaseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).Tinnitus presence (Y/N)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026